Recurrence Prophylaxis in Secondary Spontaneous Pneumothorax

Wang, Yichen; Abougergi, Marwan S.; Li, Si; Kazmierski, Dan; Patel, Prakruti; Sharma, Nishant; Ochieng, Pius

doi:10.1016/j.chest.2020.06.032

Cited by 7 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a retrospective analysis of admissions across the United States of America, same-admission recurrence prophylaxis (including medical pleurodesis, VATS or open surgery) when compared with no further intervention, was associated with a lower rate of recurrence, readmission and odds of mortality both in-hospital and at follow-up [ 54 ]. Causality cannot be assessed in this study, and there is invariably selection bias that will influence who was chosen to undergo prophylaxis procedures.…”

Section: Overview Of Management Of Secondary Spontaneous Pneumothoraxmentioning

confidence: 99%

Management of the Secondary Spontaneous Pneumothorax: Current Guidance, Controversies, and Recent Advances

Nava

Walker

2022

JCM

View full text Add to dashboard Cite

Secondary spontaneous pneumothorax (SSP) is a medical emergency where the lung collapses in the presence of underlying chronic lung disease. It is the commonest cause of spontaneous pneumothorax and results in significant breathlessness, higher morbidity, mortality, and longer hospital admissions than with patients with pneumothoraces and no underlying lung disease. This article explores the current guidance, controversies, and recent advances in the management of this condition.

show abstract

Section: Overview Of Management Of Secondary Spontaneous Pneumothoraxmentioning

confidence: 99%

Management of the Secondary Spontaneous Pneumothorax: Current Guidance, Controversies, and Recent Advances

Nava

Walker

2022

JCM

View full text Add to dashboard Cite

show abstract

“…To the best of our knowledge, a recent report by Wang et al analysed how often there were same‐admission recurrence prophylaxis (SARPs) performed in SSP admissions in the US. Chest tube insertion was performed in 66.98% of SSP admissions, 34.3% received SARP and 20.43% of patients received a conservative management without recurrence of SSP [ 12 ]. Therefore, as a take‐home message, a conservative management strategy might be considered in patients with SSP who complain of shortness of breath without haemodynamic instability.…”

Section: Discussionmentioning

confidence: 99%

Secondary spontaneous pneumothorax: a time to re‐evaluate management

Cortés-Télles

Ortíz‐Farias

Perez-Hernandez

et al. 2021

Respirology Case Reports

View full text Add to dashboard Cite

Spontaneous pneumothorax (SP) is defined as the presence of air in the pleural cavity and remains a significant health problem. Secondary SP (SSP) is associated with underlying lung diseases, such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD), and is associated with poor outcomes. The current guidelines in the management of SSP have not been updated since the last decade; therefore, new protocols focused on the management of SSP should be evaluated. We present two cases of patients admitted with SSP who were treated conservatively due to haemodynamic stability. In both cases, the pneumothoraces resolved without further complications.

show abstract

“…The caveat for this study was the absence of pleurodesis for surgical management of SSP. Wang et al [24] evaluated in a retrospective study the effect of same admission pneumothorax recurrence prophylaxis (SARP) in SSP patients, which comprised VATS, open surgery or medical pleurodesis. SARP was associated with lower mortality, lower all-cause readmission, and lower pneumothorax recurrence in SSP admissions.…”

Section: What Is the Best Intervention For Secondary Spontaneous Pneu...mentioning

confidence: 99%

Management of pneumothorax: an update

Aragaki-Nakahodo¹

2021

Current Opinion in Pulmonary Medicine

View full text Add to dashboard Cite

Purpose of reviewPneumothorax is a global health problem. To date, there is still significant variation in the management of pneumothorax. For the past few years, there have been significant developments in the outpatient management of both primary and secondary spontaneous pneumothorax (SSP). We will review the latest evidence for the management of nontraumatic pneumothorax (spontaneous and iatrogenic) to include pneumothorax associated with COVID-19 infection. Recent findingsOutpatient management of both primary and SSP may be safe and feasible. SummaryOutpatient management of both primary and SSP should be included in treatment options discussion with patients.

show abstract

Recurrence Prophylaxis in Secondary Spontaneous Pneumothorax

Cited by 7 publications

References 22 publications

Management of the Secondary Spontaneous Pneumothorax: Current Guidance, Controversies, and Recent Advances

Management of the Secondary Spontaneous Pneumothorax: Current Guidance, Controversies, and Recent Advances

Secondary spontaneous pneumothorax: a time to re‐evaluate management

Management of pneumothorax: an update

Contact Info

Product

Resources

About